News Daily News Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results Michael O'Riordan December 04, 2024
News Conference News PCR London Valves 2024 Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE Michael O'Riordan December 03, 2024
News Daily News IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication L.A. McKeown December 03, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2024 Shelley Wood December 03, 2024
News Daily News Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis Todd Neale November 28, 2024
News Daily News CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs Todd Neale November 27, 2024
News Conference News PCR London Valves 2024 Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years Michael O'Riordan November 27, 2024
News Daily News New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again Yael L. Maxwell November 27, 2024
News Daily News ZENITH: Novel Biologic Reduces Morbidity and Mortality in PAH L.A. McKeown November 26, 2024
News Conference News AHA 2024 Novel AI-Based, Noninvasive Sensor Can Accurately Measure PCWP in HFrEF Yael L. Maxwell November 25, 2024
News Daily News FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy L.A. McKeown November 25, 2024
News Daily News Closing the Left Atrial Septal Pouch For Stroke Prevention Explored in Small Trial Todd Neale November 25, 2024
News Conference News PCR London Valves 2024 Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice Michael O'Riordan November 25, 2024
News Conference News AHA 2024 REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients L.A. McKeown November 22, 2024
News Conference News AHA 2024 Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN Caitlin E. Cox November 22, 2024
News Conference News AHA 2024 ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS Michael O'Riordan November 21, 2024
News Conference News AHA 2024 Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW III Caitlin E. Cox November 21, 2024
News Conference News AHA 2024 AI Poised to Change the Landscape of Echocardiography Yael L. Maxwell November 19, 2024
Presentation AHA 2024 Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks Presenter: Steven E. Nissen November 18, 2024